Inozyme Pharma Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,423	1,124	897	1,044	2,031	1,406
Market Cap Growth	33.42%	25.29%	-14.02%	-48.61%	44.40%	-
Enterprise Value	2,100	1,901	1,581	2,180	2,583	1,508
Last Close Price	10.70	8.48	6.90	8.19	21.60	19.00
PE Ratio	37.18	33.47	-	44.01	-	99.02
PS Ratio	1.21	1.00	0.85	1.12	3.74	8.38
PB Ratio	1.13	0.89	0.82	1.01	2.68	5.55
P/TBV Ratio	-	-	-	-	-	16.68
P/FCF Ratio	6.61	5.31	4.66	10.58	21.66	125.19
P/OCF Ratio	6.39	5.14	4.62	9.66	21.46	116.25
EV/Sales Ratio	1.78	1.69	1.50	2.35	4.76	8.99
EV/EBITDA Ratio	15.45	18.17	14.72	21.97	37.90	48.27
EV/EBIT Ratio	31.34	31.53	22.65	37.23	58.60	70.39
EV/FCF Ratio	9.76	8.99	8.22	22.10	27.55	134.21
Debt / Equity Ratio	0.54	0.60	0.65	0.78	0.76	0.46
Debt / EBITDA Ratio	4.87	5.95	5.45	6.61	7.73	3.53
Debt / FCF Ratio	3.14	3.55	3.66	8.18	6.16	10.35
Asset Turnover	0.49	0.50	0.49	0.49	0.53	-
Quick Ratio	0.57	0.37	0.46	0.58	0.64	1.89
Current Ratio	0.57	0.43	0.52	0.65	0.68	1.95
Return on Equity (ROE)	3.40%	3.64%	-0.83%	-3.51%	-1.53%	-
Return on Assets (ROA)	1.82%	1.66%	2.00%	1.92%	2.69%	-
Return on Capital (ROIC)	2.37%	1.98%	2.40%	2.30%	3.23%	-
Return on Capital Employed (ROCE)	3.60%	3.00%	4.00%	3.20%	3.40%	5.80%
Earnings Yield	2.09%	2.99%	-1.66%	2.27%	-0.43%	1.01%
FCF Yield	15.13%	18.82%	21.45%	9.45%	4.62%	0.80%
Buyback Yield / Dilution	-1.17%	-2.48%	-24.59%	-17.97%	-54.74%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.